Processing

Please wait...

Settings

Settings

Goto Application

1. WO1996031462 - BENZAMIDES FOR NEURODEGENERATIVE DISORDER TREATMENT

Publication Number WO/1996/031462
Publication Date 10.10.1996
International Application No. PCT/US1996/004538
International Filing Date 03.04.1996
Chapter 2 Demand Filed 04.11.1996
IPC
A61K 31/166 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
16Amides, e.g. hydroxamic acids
165having aromatic rings, e.g. colchicine, atenolol, progabide
166having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
A61K 31/167 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
16Amides, e.g. hydroxamic acids
165having aromatic rings, e.g. colchicine, atenolol, progabide
167having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
C07C 233/65 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
233Carboxylic acid amides
64having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
65having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
C07C 237/30 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
237Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
28having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
30having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
C07C 237/42 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
237Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
28having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
42having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
CPC
A61K 31/166
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
16Amides, e.g. hydroxamic acids
165having aromatic rings, e.g. colchicine, atenolol, progabide
166having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
A61K 31/167
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
16Amides, e.g. hydroxamic acids
165having aromatic rings, e.g. colchicine, atenolol, progabide
167having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
C07C 233/65
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
233Carboxylic acid amides
64having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
65having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
C07C 237/30
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
237Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
28having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
30having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
C07C 237/38
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
237Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
28having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
38having the nitrogen atom of the carboxamide group bound to a carbon atom of a ring other than a six-membered aromatic ring
C07C 237/42
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
237Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
28having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
42having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
Applicants
  • CENTAUR PHARMACEUTICALS, INC. [US]/[US] (AllExceptUS)
  • FLITTER, William, David [GB]/[GB] (UsOnly)
  • GARLAND, William, A. [US]/[US] (UsOnly)
  • WILCOX, Allan, L. [US]/[US] (UsOnly)
  • PAYLOR, Richard, E. [US]/[US] (UsOnly)
Inventors
  • FLITTER, William, David
  • GARLAND, William, A.
  • WILCOX, Allan, L.
  • PAYLOR, Richard, E.
Agents
  • BENZ, William, H.
Priority Data
08/415,24803.04.1995US
08/415,67703.04.1995US
08/415,69403.04.1995US
08/415,84703.04.1995US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) BENZAMIDES FOR NEURODEGENERATIVE DISORDER TREATMENT
(FR) BENZAMIDES DESTINES AU TRAITEMENT DE TROUBLES NEURO-DEGENERATIFS
Abstract
(EN)
Disclosed are pharmaceutical compositions containing as active ingredient a compound of formula (I) wherein R' is a saturated alkyl of 3 to 5 carbon atoms, each R is independently -NO2 or -NH2 or -NHCOCH3, and n is 1 or 2. Some of these compounds are new. A process for their preparation is also disclosed, as well as their use in the manufacture of medicaments for treating conditions characterised by progressive loss of central nervous system such as Parkinson's disease or Alzheimer's.
(FR)
Des compositions pharmaceutiques contiennent en guise d'ingrédient actif un composé de formule (I) où R' représente au alkyle saturé doté de 3 à 5 atomes de carbone, R représente indépendemment -NO2, -NH2 ou -NHCOCH3, et n vaut 1 ou 2. Certains de ces composés sont nouveaux. On décrit aussi un procédé permettant de les préparer, ainsi que leur utilisation dans la fabrication de médicaments destinés à traiter des troubles caractérisés par une perte progressive des fonctions du système nerveux central, tels que les maladies de Parkinson ou d'Alzheimer.
Latest bibliographic data on file with the International Bureau